http://www.fpnotebook.com/
Campral
Aka: Campral, Acamprosate
- Indications
- Maintenance of Alcohol abstinence
- Contraindications
- Severe renal insufficiency (CrCl <30 ml/min)
- Advanced Cirrhosis
- Mechanism
- Balances GABA and glutamate neurotransmitters
- Blocks glutaminergic N-methyl-D-Aspartate receptors
- Activates GABA Type A receptors
- Reduces anxiety from abstinence
- Efficacy
- Reduces short and longterm relapse rates
- Dosing
- Campral 666 mg (two 333 mg tabs) PO three times daily
- Start with one three times daily
- Increase with one additional tablet daily each week
- Slow titration reduces gastrointestinal side effects
- Indications to decrease to 666 mg AM, 333 noon, 333 PM
- Weight <60 kg
- Renal insufficiency
- Creatinine Clearance <50 ml/min, but >30 ml/min
- Contraindicated if Creatinine Clearance <30 ml/min
- Drug interactions
- No interaction with Alcohol or Benzodiazepines
- No interaction with Disulfiram (Antabuse)
- Adverse effects
- Transient Diarrhea (10%)
- Disadvatages
- Cost: $125/month
- References
- Mason (2001) J Clin Psychiatry 62:42-8